Punjab's Mukh Mantri Sehat Yojana: A Lifeline for Cancer Patients
Addressing the Financial Burden of Cancer Treatment
Receiving a cancer diagnosis can be an overwhelming experience for families. The anxiety often intensifies when the question arises: “Can we afford the necessary treatment?” This concern is what the Punjab government's Mukh Mantri Sehat Yojana, led by Chief Minister Bhagwant Mann, aims to alleviate. As reported by the State Health Agency (SHA), up until July 18, 2026, 8,069 cancer patients benefited from cashless treatment under this initiative, with the government investing Rs 20.22 crore in their healthcare.
These statistics represent countless families facing critical decisions during a time when prompt action is crucial. Advances in medical treatments such as surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapies have significantly improved patient outcomes. However, timely access to these treatments is essential for their effectiveness.
The age distribution of the beneficiaries reveals a significant trend. While cancer is often linked to older individuals, data indicates that a substantial number of patients are in their prime working years. Among those treated under the Mukh Mantri Sehat Yojana, 4,285 patients were aged between 36 and 60, making this the largest demographic. Additionally, 3,376 patients were over 60, while 399 were aged 17 to 35, and nine were under 17.
For many families, a cancer diagnosis can quickly escalate into a financial crisis. Treatment often requires frequent hospital visits, costly procedures, and long-term care. Even when the disease is manageable, the financial burden can dictate the speed at which a patient can begin their treatment journey.
Darshan Devi from Samana understands this uncertainty all too well. As her pain intensified, doctors recommended surgery, but the estimated cost of Rs 4-5 lakh posed a significant challenge for her family. Thanks to the Mukh Mantri Sehat Yojana, her surgery was conducted without any out-of-pocket expenses, transforming the scheme from a mere healthcare benefit into a crucial facilitator of timely treatment.
Data from Punjab indicates a steady demand for cancer care throughout the year. The number of patients receiving treatment rose from 842 in January to 1,080 in February, 1,175 in March, and 1,350 in April. Although there was a slight dip to 1,275 in May, June saw the highest number of treatments at 1,468 patients. In just the first 18 days of July, 879 patients had already received care.
This increasing demand for cancer services highlights a broader national issue. The Indian Council of Medical Research (ICMR) estimated that India recorded nearly 14.6 lakh new cancer cases in 2022, with projections indicating a rise in the coming years due to changing lifestyles, an aging population, and improved detection methods.
However, statistics alone do not tell the entire story. Cancer is a disease where timing is critical for successful outcomes. Delays in diagnosis or treatment can allow the disease to advance, complicating care and increasing costs. For families already under pressure, securing funds quickly can become an additional struggle.
Since the Mukh Mantri Sehat Yojana's launch on January 8, 2026, a total of 2,68,274 beneficiaries have accessed treatment through the scheme, resulting in 5,31,386 treatment cases. As of July 20, 2026, the total expenditure on treatment under this initiative has reached Rs 950.35 crore.
Punjab's Health and Family Welfare Minister, Dr. Balbir Singh, emphasized that the Bhagwant Mann Government's goal through the Mukh Mantri Sehat Yojana is to ensure that financial constraints do not hinder access to cancer treatment. “Cancer is emerging as a significant public health challenge. Early detection and timely intervention can greatly enhance outcomes. Through this scheme, eligible patients can access quality cancer care without the burden of treatment costs,” he stated. He also urged the public to be vigilant about warning signs such as persistent lumps, unexplained weight loss, abnormal bleeding, prolonged cough, or changes in bowel and bladder habits.